Prostate Cancer More Likely To Return In Blacks Than Whites
African-American men are more likely to have their prostate cancer return after treatment, but their disease is no more aggressive when it does recur than that of their white counterparts.
|
Soy Protein May Reduce Prostate Cancer Risk
Study suggests consumption of soy protein may play a role in reducing the risk of prostate cancer.
|
Prostate Cancer Tumors Not More Aggressive In Black Men Than White Men
Black men do not necessarily have more aggressive prostate cancer tumors than white men.
|
Web Site Helps Men Evaluate Risk Of Prostate Cancer
In 2007, more than 218,000 American men will be diagnosed with prostate cancer, and more than 27,000 men will die from the disease.
|
The Importance Of Prostate Cancer Screening
What is a Prostate-Specific Antigen (PSA) and why is it important for men to know their PSA number?
|
CyberKnife System Shows Momentum As Treatment Option For Prostate Cancer
More than 1,000 men have been treated for prostate cancer with Accuray's CyberKnife Robotic Radiosurgery System.
|
Real-Time System Helps Plant 'Seeds' Against Prostate Cancer
Radiation oncologists and urologists have begun using a real-time system to implant radiation-emitting seeds in prostate cancer patients.
|
Prostate Cancer Drug Aids Early Diagnosis Of Aggressive Form Of Disease
Men now have another good reason to consider taking finasteride, a well-known generic drug that shrinks an enlarged prostate and reduces the risk of getting prostate cancer by 25 percent.
|
Chemical Diversity Initiates International Prostate Cancer Discovery Partnership
Researchers are undertaking a partnership to develop novel small molecule therapies for the prevention and treatment of prostate cancer (PRC).
|
Radiation therapy technique reduces length of prostate cancer treatment
This new treatment for early state prostate cancer mimics the dose deposition of brachytherapy, but it is done noninvasively, in an outpatient setting, without making any incisions, needle punctures or anesthesia.
|
Prostate Cancer Care Legislation Would Fund Lifesaving Imaging Research
Elijah Cummings, Albert Wynn will co-sponsor legislation that would fund the development of technological advances in the fight against prostate cancer that kills one man every 18 minutes.
|
Granholm, MDCH Recognize September As Prostate Cancer Awareness Month
Governor Granholm and the Michigan Department of Community Health are again recognizing September as Prostate Cancer Awareness.
|
Prostate Cancer Research Funding For Black Men Inadequate
Black men are more than twice as likely as white men to develop prostate cancer and die from it.
|
Prostate Cancer Education Program Targets Black Men In Barbershops
Providing black men with information about prostate cancer during visits to their local barbers has been an effective educational and screening tool.
|
Complementary, Alternative Treatments Do Not Interfere With Conventional Prostate Cancer Care
Should patients receiving radiation and other conventional treatments for prostate cancer cease consumption of naturopathic products?
|
Unique Grape Skin Extract Inhibits Prostate Cancer Cell Growth
Laboratory experiments show that an extract of the skin of muscadine grapes can inhibit growth of prostate cancer cells in the laboratory.
|
More Prostate Cancer Screening Has Little Effect on Detection of Aggressive Cancer
More prostate cancers were detected among men who were screened every two years than men screened every four years.
|
Asian Men Have Higher Survival Rates From Prostate Cancer Than White Men
The average survival time for certain Asian-Americans with prostate cancer is longer than it is for whites.
|
Device Detects Small Movements During Radiation Treatment For Prostate Cancer
Radiation for prostate cancer treatment involves targeting intense beams in a very precise fashion to a relatively small area.
|
Study Combines HIFU, Chemotherapy For Localized Prostate Cancer
EDAP TMS is currently conducting clinical investigations in France under an approved clinical trial combining the company's Ablatherm-HIFU device with chemotherapy using docetaxel.
|
New Genetic Cause Identified in Prostate Cancer Development
Research Studies Funded by Prostate Cancer Foundation Help Find a Master "On" Switch for Prostate Cancer.
|
First biomarker discovered that predicts prostate cancer outcome
Researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery.
|
Researchers Find Family Of 'On Switches' That Cause Prostate Cancer
Researchers have discovered how genes turn on the switch that leads to prostate cancer.
|
D.C. Denies Prostate Cancer Vaccine, Provenge
Many in the prostate cancer community are still outraged over the FDA's decision to deny approval for the immunotherapy drug Provenge.
|
FDA Should Wait About Satraplatin For Treatment Of Prostate Cancer
FDA should wait for the overall survival analysis of satraplatin for the treatment of hormone-refractory prostate cancer.
|
Simple interventions may increase prostate cancer screening
Primary care doctors should promote discussion of prostate cancer and personalized decisions about prostate cancer screening options.
|
Genaera Discontinues LOMUCIN In Cystic Fibrosis And Squalamine In Prostate Cancer Studies
Genaera Corporation and Cystic Fibrosis Foundation Therapeutics have agreed for reasons of futility to discontinue the Phase 2 study of LOMUCIN for the treatment of cystic fibrosis (CF).
|
Satraplatin - Prednisone Combination For Treatment Of Patients With Metastatic Hormone-Refractory Prostate Cancer
Pharmion submitted marketing authorization application Satraplatin in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer who have failed prior chemotherapy.
|
HIFU For Prostate Cancer In Niagara Falls
USHIFU has opened its newest Prostate Cancer clinic in Niagara Falls Canada, 15 miles outside of Buffalo, New York.
|
Health benefit of pomegranate juice on prostate cancer and the heart
Scientific findings suggest that pomegranates may one day find a place in healthful diets, benefit prostate cancer and heart.
|
Prostate cancer treatment options: Info about new prostate treatments
For many men with early-stage prostate cancer, sorting out the treatment options can be overwhelming. The most important thing to do is to take your time and make sure you explore all prostate cancer treatment choices thoroughly.
|
Prostate benefits from red wine for cancer prevention
Men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine
|
Rockland County Department Of Health Offers Free Prostate Cancer Screening
Rockland County Department of Health encourages men to get tested for prostate cancer during a free screening this Saturday, June 16th from 11 a.m. - 3 p.m. at Nyack Hospital as part of a Health Fair.
|
Circulating Tumor Cells Predict How Hormone-Resistant Prostate Cancer Patients Fare
The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy.
|
Flaxseed Stunts Growth Of Prostate Tumors
Flaxseed, an edible seed that is rich in omega 3-fatty acids and fiber-related compounds known as lignans, is effective in halting prostate tumor growth.
|
PC Detect For Prostate Cancer Screening Available
PC Detect, Panacea Pharmaceuticals' prostate cancer screening test, is now available from Panacea Laboratories.
|
Novacea, Schering-Plough To DevelopA Novel Treatment For Prostate Cancer
Novacea and Schering-Plough Corporation have entered into an exclusive worldwide license agreement for the development and commercialization of Asentar for prostate cancer treatment.
|
June Is Prostate Cancer Awareness Month
Prostate cancer is the most common type of cancer diagnosed in men and the second leading cause of cancer death in Kansas.
|
Group To Evaluate Prostate Cancer DNA Vaccine
Cancer Center Karolinska have jointly developed a DNA Vaccine to stimulate a patient's immune system to fight and kill prostate cancer cells remaining in the body after removal or irradiation of the prostate gland.
|
Prostate Cancer Clinical Study Resumes At Virginia Urology Center
EDAP TMS S.A. announced the continuation of its US Phase II/III clinical trial with treatment of an additional two patients at Virginia Urology Center, Richmond, Virginia.
|
